文献速递儿科影像外周血管技术与安全US

体外支持中的超声造影:体外研究及在体外子宫环境维持的极早产胎羔中的初步经验与安全性数据

Contrast-Enhanced Ultrasound in Extracorporeal Support: In Vitro Studies and Initial Experience and Safety Data in the Extreme Premature Fetal Lamb Maintained by the Extrauterine Environment for Neonatal Development.
PubMed 文献 · J Ultrasound Med · 2018-12-17

研究在体外和体内体外支持模型中评估超声造影剂对血流动力学和支持设备的影响。体外各剂量(0.1-4 mL)跨膜氧合器参数无差异(P ≥ .09),首过造影剂破坏率3%-14%。体内7只极早产胎羔共17次CEUS检查前后血流动力学和血清实验室值无差异(P ≥ .08),氧合器膜脂质染色均阴性,提示造影剂对氧合器及测量参数无可检测影响。

要点

  • 体外各剂量(0.1-4 mL)超声造影剂跨膜氧合器测量参数无差异(P ≥ .09)。
  • 体内17次CEUS检查前后血流动力学及血清实验室值无差异(P ≥ .08)。
  • 氧合器膜脂质染色均阴性,未检出造影剂附着。

核心结论

  • 超声造影剂在体外和体内研究中对膜氧合器及测量参数无可检测影响,为体外支持场景下使用CEUS提供了额外安全性数据。

研究设计与样本

  • 体外研究经膜氧合器近端递增弹丸注射超声造影剂并获取超声 cine clips;体内7只极早产胎羔从胎盘支持转移至体外子宫环境维持,行CEUS检查并比较前后参数;氧合器膜取自体外回路、研究动物(n = 4)和对照动物(n = 4)行脂质染色。

诊断标准与关键数值

  • 体外首过跨膜氧合器造影剂破坏率为3%-14%,随时间造影强度逐渐下降。

临床应用与阅片要点

  • 原文未据此给出推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the effects of ultrasound contrast agent (UCA) administration on hemodynamic parameters and support equipment in in vitro and in vivo models of extracorporeal support.

METHODS: In vitro, incrementally increasing bolus doses of a UCA were administered proximal to a membrane oxygenator, and ultrasound cine clips were obtained. The rates of microbubble destruction across the oxygenator and over time were calculated from time-intensity-curves. Measurements across the membrane oxygenator were recorded and compared by a repeated-measures analysis of variance. In vivo, 7 premature fetal lambs were transferred from placental support to the extrauterine environment for neonatal development. Contrast agent boluses were administered for contrast-enhanced ultrasound (CEUS) examinations. Hemodynamic parameters and serum laboratory values were evaluated before and after the examinations by paired t tests. For oxygenator staining, oxygenator membranes from the in vitro circuit, study animals (n = 4), and control animals (n = 4) were stained for the adherent UCA.

RESULTS: In vitro, with all doses (0.1-4 mL), there was no difference in measured parameters across the oxygenator (P ≥ .09). Contrast agent destruction (3%-14%) across the oxygenator was observed at the first pass with a progressive decline in contrast intensity over time. In vivo, there was no difference in hemodynamic parameters or serum laboratory values (P ≥ .08) with any CEUS examination (n = 17). For oxygenator staining, all oxygenator membranes were negative for UCA with lipid staining.

CONCLUSIONS: The UCA had no detectable effect on the oxygenator or measured parameters in in vitro and in vivo studies, thus providing additional safety data to support the use of CEUS in the setting of extracorporeal support.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Didier RA, Sridharan A, Lawrence K, et al. Contrast-Enhanced Ultrasound in Extracorporeal Support: In Vitro Studies and Initial Experience and Safety Data in the Extreme Premature Fetal Lamb Maintained by the Extrauterine Environment for Neonatal Development. J Ultrasound Med. 2018. PMID: 30560564. doi:10.1002/jum.14885

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。